Idexx Laboratories | IDXX - Gross Profit On Sales

Stock Price
568.30
Daily Change
-6.65 -1.16%
Monthly
2.01%
Yearly
30.05%
Q2 Forecast
553.82

Idexx Laboratories reported $658.11M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Accuray USD 41.89M 7.42M Dec/2024
Align Technology USD 683.59M 44.39M Dec/2025
AngioDynamics USD 44.78M 2.93M Sep/2025
Dentsply International USD 443M 2M Dec/2025
Dexcom USD 792.7M 61.3M Dec/2025
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Fujifilm JPY 347.51B 14.74B Dec/2025
Globus Medical USD 535.95M 49.28M Dec/2025
Henry Schein USD 1.06B 37M Dec/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 568.6M 58.5M Dec/2025
Integra LifeSciences USD 217.1M 10.11M Dec/2025
Intuitive Surgical USD 1.83B 73.8M Mar/2026
Masimo USD 247.3M 16.7M Dec/2025
Neogen USD 99M 7.7M Dec/2025
Orthofix International USD 153.28M 4.76M Dec/2025
Phibro Animal Health USD 133.5M 12.6M Dec/2025
ResMed USD 878.72M 57.9M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Steris USD 655.5M 9.6M Dec/2025
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.45M 144.2M Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Zoetis USD 1.64B 73M Dec/2025